John A Detre

Title: John A. Detre: Innovator in Optical Measurement of Tissue Blood Flow

Introduction

John A. Detre is a prominent inventor based in Wynnewood, PA (US). He has made significant contributions to the field of medical technology, particularly in the area of optical measurement of tissue characteristics. His innovative work has implications for understanding blood flow and oxygenation in deep tissues.

Latest Patents

John A. Detre holds a patent for an invention titled "Optical measurement of tissue blood flow, hemodynamics and oxygenation." This invention encompasses a device, system, and method designed to determine the characteristics of deep tissue. The novel method involves measuring blood flow rate and oxygenation characteristics of the tissue, as well as determining oxygen metabolism based on these measurements. The blood flow rate characteristics are assessed through light fluctuations caused by the tissue, while the oxygenation characteristics are evaluated based on the transmission of light through the tissue, considering the wavelength of light. This technology can be applied to layered tissues, such as portions of the brain, and can measure tissue characteristics during varying levels of exercise intensity. John A. Detre has 1 patent to his name.

Career Highlights

John A. Detre is affiliated with the University of Pennsylvania, where he continues to advance research in his field. His work has garnered attention for its potential applications in medical diagnostics and treatment.

Collaborations

Some of his notable coworkers include Arjun Gaurang Yodh and Joel H. Greenberg. Their collaborative efforts contribute to the ongoing research and development in optical measurement technologies.

Conclusion

John A. Detre's innovative contributions to the field of optical measurement of tissue characteristics highlight his role as a leading inventor in medical technology. His work not only enhances our understanding of tissue dynamics but also paves the way for future advancements in healthcare.